Literature DB >> 10878614

Temporo-spatial distribution of endothelial-monocyte activating polypeptide II, an anti-angiogenic protein, in the mouse embryo.

F Zhang1, M A Schwarz.   

Abstract

We describe the temporo-spatial distribution of Endothelial-Monocyte Activating Polypeptide (EMAP) II in order to better understand what role this anti-angiogenic proteins may play in fetal development. In situ hybridization, immunohistochemistry, and Western analysis were performed on fetal, neonatal, and adult tissue. EMAP II was first detected only within the central nervous system on 9 days postcoitum (dpc). Subsequently, at 11 through 18 dpc, EMAP II expression was detected in the respiratory, central nervous, cardiovascular, urogenital systems, sense organs, and digestive tract. EMAP II mRNA and protein was localized to the epithelium, with its highest expression in neurons, blood vessels, and at sites of epithelial-mesenchymal interaction. The temporo-spatial distribution of EMAP II suggests that it could play an important role in morphogenesis of the vertebrate embryo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878614     DOI: 10.1002/1097-0177(200007)218:3<490::AID-DVDY1005>3.0.CO;2-C

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  7 in total

1.  Lung self-assembly is modulated by tissue surface tensions.

Authors:  Margaret A Schwarz; Haihua Zheng; Susan Legan; Ramsey A Foty
Journal:  Am J Respir Cell Mol Biol       Date:  2010-07-08       Impact factor: 6.914

2.  Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesis.

Authors:  Chujun Yuan; Lin Yan; Pallavi Solanki; Stephen F Vatner; Dorothy E Vatner; Margaret A Schwarz
Journal:  J Mol Cell Cardiol       Date:  2014-11-29       Impact factor: 5.000

3.  Influence of aminoacyl-tRNA synthetase complex-interacting multifunctional protein 1 on epithelial differentiation and organization during lung development.

Authors:  Daniel D Lee; Alexandra Hochstetler; Eric Sah; Haiming Xu; Chinn-Woan Lowe; Sara Santiaguel; Janet Lea Thornton; Adam Pajakowski; Margaret A Schwarz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-06-24       Impact factor: 5.464

4.  Control of stromal keratitis by inhibition of neovascularization.

Authors:  M Zheng; M A Schwarz; S Lee; U Kumaraguru; B T Rouse
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

5.  Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of Prematurity.

Authors:  Daniel D Lee; Charitharth V Lal; Elizabeth A Persad; Chinn-Woan Lowe; Anna M Schwarz; Niranjan Awasthi; Roderich E Schwarz; Margaret A Schwarz
Journal:  Am J Respir Cell Mol Biol       Date:  2016-10       Impact factor: 6.914

6.  Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation.

Authors:  Yao Chen; Susan K Legan; Anne Mahan; Janet Thornton; Haiming Xu; Margaret A Schwarz
Journal:  Respir Res       Date:  2012-01-03

7.  Cell proliferation and migration are modulated by Cdk-1-phosphorylated endothelial-monocyte activating polypeptide II.

Authors:  Margaret A Schwarz; Janet Thornton; Haiming Xu; Niranjan Awasthi; Roderich E Schwarz
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.